Skip to main content

CVS Health Corp

CVS
Exchange
NYSE
Industry
Retail-Drug Stores and Proprietary Stores
SEC CIK
0000064803

No open-market purchases or sales by CVS Health Corp insiders were filed in the last 90 days; 2,074 institutions reported holding it in 13F filings for Q2 2026, worth $117.5B in total; 3 superinvestors hold it, including Viking Global Investors and Fairfax Financial.

Holders of 5% or more of CVS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CVS Health Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CVS
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A8.30%105.3M shares+1.20 ppfrom 7.10%Apr 17, 20252 filingsJul 16, 2025SEC
Capital World Investors13G5.50%68.8M sharesNewMay 13, 20251 filingMay 13, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on CVS Health Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CVS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 26, 20265:43 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A8.30%105.3M shares+1.20 ppfrom 7.10%Jun 30, 2025SEC
May 13, 202511:44 AM ETCapital World Investors13G5.50%68.8M sharesNewMar 31, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A7.10%89.2M shares–Mar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell CVS Health Corp shares.

No Form 144 notices for CVS Health Corp are on file.